Majority of your patients had been adopted up every month. Hence, the potential for recall bias in ADR reporting couldn't be ruled out. . have also noticed which the dose modification of nevirapine is not really demanded in individuals acquiring both nevirapine and rifampicin, and there is no major change https://hivhub.in/product-category/hiv-medicine/